Trials / Recruiting
RecruitingNCT05993910
Prospective Hyperthermia Database in Cancer Patients (HT Register)
Prospektive Hyperthermie-Datenbank Bei Krebspatienten (HTRegister)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Pirus Ghadjar · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This monocentric study registry records all cancer patients at the Charité which are treated with hyperthermia to examine the therapeutic use of hyperthermia in cancer patients in the general application and to obtain an accurate risk-benefit balance After confinement in this database are the patients prospectively in order to complications, disease status and survival status tracked. Furthermore there is the possibility in the course of this study to an optional take part in translational accompanying research with the aim of prognostic factors for response to hyperthermia treatment.
Detailed description
A total of 1000 patients with various diseases with the indication for hyperthermia in addition to standard oncological therapy (radiation therapy, chemotherapy, radiochemotherapy) will be included in this registry protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hyperthermie Register | * die Höhe der Temperatur im Zielgebiet (42,5 bis 43 °C), * die Dauer der Anwendung und * die simultane Therapie mit Chemo- und/oder Strahlentherapie |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2028-10-31
- Completion
- 2028-10-31
- First posted
- 2023-08-15
- Last updated
- 2023-08-15
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT05993910. Inclusion in this directory is not an endorsement.